Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRI
CRI logo

CRI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Carter's Inc (CRI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
35.590
1 Day change
-0.48%
52 Week Range
44.440
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Carter's Inc (CRI) is not a strong buy at the moment for a beginner investor seeking long-term opportunities. While the company shows some signs of a turnaround, the macroeconomic uncertainties, tariff impacts, and potential store closures weigh heavily on its outlook. The lack of strong trading signals and mixed sentiment from analysts further support a hold recommendation.

Technical Analysis

The MACD is positive and expanding, indicating a mild bullish trend. However, the RSI is neutral at 44.429, and moving averages are converging, suggesting no clear directional momentum. The stock is trading near its pivot level of 34.734, with support at 34.006 and resistance at 35.462.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
6

Positive Catalysts

  • Revenue, net income, and EPS showed YoY growth in Q4 2025, indicating some operational improvements. Analysts have highlighted a potential turnaround story under the new CEO, with some upgrades and price target increases.

Neutral/Negative Catalysts

  • Analysts remain cautious due to macroeconomic uncertainties, and insider and hedge fund activity are neutral.

Financial Performance

In Q4 2025, revenue increased by 7.65% YoY to $925.45 million, net income rose by 4.63% YoY to $63.03 million, and EPS grew by 4.09% YoY to 1.78. However, gross margin dropped to 43.24%, down 9.56% YoY, indicating cost pressures.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed on Carter's. Citi and Monness Crespi upgraded the stock to Buy with price targets of $50 and $45, respectively, citing turnaround potential. UBS raised its price target to $40 but maintained a Neutral rating. Needham initiated coverage with a Hold rating, expressing caution due to macro uncertainties.

Wall Street analysts forecast CRI stock price to fall
3 Analyst Rating
Wall Street analysts forecast CRI stock price to fall
1 Buy
0 Hold
2 Sell
Moderate Sell
Current: 35.760
sliders
Low
25
Averages
34.67
High
50
Current: 35.760
sliders
Low
25
Averages
34.67
High
50
Needham
Hold
initiated
AI Analysis
2026-03-26
Reason
Needham
Price Target
AI Analysis
2026-03-26
initiated
Hold
Reason
Needham initiated coverage of Carter's with a Hold rating and no price target. The firm is "encouraged" by the recent inflection in the company's direct-to-consumer comps. However, it is prudent to take a "wait-and-see approach" on the shares given the macro uncertainty, the analyst tells investors in a research note.
Monness Crespi
Neutral -> Buy
upgrade
$45
2026-03-02
Reason
Monness Crespi
Price Target
$45
2026-03-02
upgrade
Neutral -> Buy
Reason
Monness Crespi upgraded Carter's to Buy from Neutral with a $45 price target. The firm says tariffs are "masking" the company's turnaround.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRI
Unlock Now

People Also Watch